NCT04300114 2024-03-28A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyJiangsu HengRui Medicine Co., Ltd.Phase 3 Terminated5 enrolled